Celularity (CELUW) Total Current Liabilities (2018 - 2025)
Celularity (CELUW) reported Total Current Liabilities of $80.8 million for Q4 2025, up 50.45% year-over-year from $53.7 million in Q4 2024, and up 23.65% quarter-over-quarter from $65.3 million in Q3 2025.
Celularity (CELUW) Total Current Liabilities (2018 - 2025) Analysis & Trends
Celularity (CELUW) has 8 years of Total Current Liabilities data on file, last reported at $80.8 million in Q4 2025.
- Total Current Liabilities for Q4 2025 came in at $80.8 million, up 50.45% year-over-year; the trailing twelve-month figure through Dec 2025 was $80.8 million (up 50.45% YoY), and the FY2025 annual result was $80.8 million, up 50.45% from the prior year.
- Total Current Liabilities advanced to $80.8 million in Q4 2025 per CELUW's latest filing, from $65.3 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $84.6 million in Q3 2023 and troughed at $5.2 million in Q1 2021.
- A 5-year average of $54.0 million and a median of $65.1 million in 2023 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2021 and 2024: Total Current Liabilities soared 20571.7% in 2021, then slipped 20.24% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $26.2 million in 2021, then soared by 136.75% to $62.1 million in 2022, then increased by 8.39% to $67.3 million in 2023, then fell by 20.24% to $53.7 million in 2024, then surged by 50.45% to $80.8 million in 2025.
- Business Quant data shows CELUW's Total Current Liabilities at $80.8 million in Q4 2025, $65.3 million in Q3 2025, and $69.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | Celularity | - | - | -3.27 Mn | 80.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 80.76 Mn |
| Sep 30, 2025 | 65.31 Mn |
| Jun 30, 2025 | 69.23 Mn |
| Mar 31, 2025 | 58.69 Mn |
| Dec 31, 2024 | 53.68 Mn |
| Sep 30, 2024 | 76.17 Mn |
| Jun 30, 2024 | 67.90 Mn |
| Mar 31, 2024 | 66.04 Mn |
| Dec 31, 2023 | 67.30 Mn |
| Sep 30, 2023 | 84.63 Mn |
| Jun 30, 2023 | 64.98 Mn |
| Mar 31, 2023 | 66.46 Mn |
| Dec 31, 2022 | 62.09 Mn |
| Sep 30, 2022 | 69.22 Mn |
| Jun 30, 2022 | 32.94 Mn |
| Mar 31, 2022 | 26.03 Mn |
| Dec 31, 2021 | 26.23 Mn |
| Sep 30, 2021 | 29.21 Mn |
| Jun 30, 2021 | 7.29 Mn |
| Mar 31, 2021 | 5.16 Mn |